APOA1 and urinary bladder carcinoma: Peng et al. (Peng et al., 2019) found that high-grade bladder cancer (BC) patients have significantly higher APOA-1 levels than do low-grade BC patients, indicating that circulating APOA-1 protein may be a novel biomarker for BC diagnosis and prognosis monitoring.